Männedorf, Switzerland 7/15/10; Poway, CA 7/15/10—Tecan has announced an agreement to sell its REMP AG subsidiary and related assets to NEXUS Biosystems, a supplier of sample management systems, for CHF 12 million ($11 million = CHF 1.06 = $1) and additional deferred payments of $4.4–$7.7 million. Based in Oberdiessbach, Switzerland, with 120 employees, REMP provides sample management systems and consumables and had 2009 sales of CHF 35.7 million ($32.7 million = CHF 1.09 = $1) and an operating profit of CHF 0.1 million ($0.1 million) (see IBO 3/15/10). Tecan will take an estimated impairment charge of CHF 28 million ($27 million) in the first half. Tecan and NEXUS plan to collaborate on additional products. Tecan stated that REMP’s portfolio of small- and large-size systems and its European presence will complement US-based NEXUS’s high-speed, mid-size systems. Domingo Messerli, head of Tecan’s Sample Management Business Unit, will resign from Tecan’s Executive Board. The sale is expected to close in two months.